Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Oncotelic Therapeutics's operating margin for the twelve months ending Dec 31, 2023 was -9497.2%. For fiscal 2023 it was -9497.2%, against -435.7% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -9497.2% | −9061.5 |
| FY2020 | Dec 31, 2020 | -435.7% | +8280.1 |
| FY2013 | Dec 31, 2013 | -8715.8% | −3541.4 |
| FY2012 | Dec 31, 2012 | -5174.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -337.4% | – |
| Q3 FY2023 | Sep 30, 2023 | 20.7% | – |
| Q2 FY2020 | Jun 30, 2020 | 1.0% | – |
| Q1 FY2020 | Mar 31, 2020 | -777.1% | – |
See a number that looks wrong?